Rogco LP’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$526K Buy
572
+5
+0.9% +$5.07K 0.18% 82
2025
Q4
$609K Buy
567
+78
+16% +$74.6K 0.2% 77
2025
Q3
$373K Buy
489
+477
+3,975% +$355K 0.13% 90
2025
Q2
$9.35K Hold
12
﹤0.01% 169
2025
Q1
$9.91K Hold
12
﹤0.01% 171
2024
Q4
$9.26K Hold
12
﹤0.01% 178
2024
Q3
$10.6K Hold
12
﹤0.01% 181
2024
Q2
$10.9K Hold
12
﹤0.01% 179
2024
Q1
$9.34K Hold
12
﹤0.01% 195
2023
Q4
$7K Sell
12
-8
-40% -$4.67K ﹤0.01% 205
2023
Q3
$10.7K Buy
+20
New +$10.3K 0.01% 186

Other funds holding LLY

Rogco LP's LLY Position: Q1 2026 in Review

Rogco LP increased its Eli Lilly (LLY) stake by 0.88% in Q1 2026, buying an estimated $5.07K and bringing the position to 572 shares worth $526K. The position accounts for 0.18% of the portfolio, ranked #82.

Rogco LP first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $609K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Rogco LP held 572 shares of Eli Lilly worth $526K as of Q1 2026.
  • Rogco LP bought 5 Eli Lilly shares in Q1 2026, an estimated $5.07K.
  • Eli Lilly made up 0.18% of Rogco LP's portfolio in Q1 2026, its #82 holding.
  • Rogco LP first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • Rogco LP's Eli Lilly position peaked at $609K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Rogco LP's 13F filing for Q1 2026, filed 5 May 2026.